Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

David Walker

1PUBLICATIONS
15CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jun 21, 2023
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.

Oscar E Reyes Gaido, Nikoleta Pavlaki, Jonathan M Granger

Pageof 1

Frequent Collaborators

1 joint publications

Oscar E Reyes Gaido

1 joint publications

Nikoleta Pavlaki

1 joint publications

Jonathan M Granger

1 joint publications

Olurotimi O Mesubi

1 joint publications

Bian Liu

1 joint publications

Brian L Lin

1 joint publications

Lubika J Nkashama

1 joint publications

Mohit M Hulsurkar

1 joint publications

Lauren E Dorn

1 joint publications

Kimberly M Ferrero

Frequent Collaborators

1 joint publications

Oscar E Reyes Gaido

1 joint publications

Nikoleta Pavlaki

1 joint publications

Jonathan M Granger

1 joint publications

Olurotimi O Mesubi

Top Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on : May 16, 2020

4.7K
See more related videos

Top Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on : May 16, 2020

4.7K
See more related videos